618 matches for your search in the start-up spotlight
rss
Enduro Genetics is a deeptech company transforming biomanufacturing by solving the challenge of microbial productivity. Its patented synthetic addiction technology, Enduro Sense, boosts yields, reduces costs and waste, and enables scalable, sustainable production across biochemicals, alternative ...
Akribion Therapeutics is developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion. Our G-dase® E nuclease has the ability to kill cells by shredding DNA and RNA, but only if there is a highly specific match between the guide RNA and an intracellular RNA sequence, ...
CellX Biosolutions is an ETH Zurich-born startup, on a mission to redefine how we treat chemical pollutants. While traditional methods of chemical disposal, such as incineration, are costly and not sustainable, our pioneering approach leverages Nature's Master Recyclers, bacteria, to address ...
CellX Biosolutions is an ETH Zurich-born startup, on a mission to redefine how we treat chemical pollutants. While traditional methods of chemical disposal, such as incineration, are costly and not sustainable, our pioneering approach leverages Nature's Master Recyclers, bacteria, to address ...
Arctic Therapeutics is an Icelandic drug discovery and development company established in 2015 as a spin-off from the US-based Center for Applied Genomics (CAG), a research center at the Children’s Hospital of Philadelphia led by ATx founder Hakon Hakonarson, MD, PhD. ATx leverages the ...
Leyden Labs is working to free people from the threat of respiratory viruses. Leyden Labs is leveraging its Mucosal Protection Platform to develop a portfolio of candidates aimed at providing protection against influenza, coronaviruses, and other respiratory viruses through a new class of broadly ...
ThirdLaw Molecular is a targeted drug discovery company that is reimagining molecular therapeutics by pioneering the development of Spiroligomer™ technology. This is a novel, patent-protected chemical platform of synthetic, modular, fused-ring structures incorporating a diverse range of ...
Developed a metabolome based a diagnostic gut function test (GFT). GFT goes beyond diagnosis to help designing personalized probiotic formulation for prophylaxis and intervention.
Noema Pharma is a clinical-stage biotech company advancing a portfolio of transformative therapeutics utilizing first-in-disease approaches targeting neuroscience-based conditions with high unmet need. Noema has four programs currently in active Phase 2 clinical trials evaluating pain in ...
